Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Current Value
$4.251 Year Return
Current Value
$4.251 Year Return
Market Cap
$117.25M
P/E Ratio
-42.75
1Y Stock Return
-50.46%
1Y Revenue Growth
278.09%
Dividend Yield
0.00%
Price to Book
-22.7
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BRC | 0.01% | $3.31B | +29.76% | 1.35% |
GIS | 0.02% | $34.85B | -2.91% | 3.78% |
NINE | 0.02% | $49.99M | -42.44% | 0.00% |
BCAN | 0.02% | $72.87M | -99.75% | 0.00% |
ESGR | 0.04% | $4.93B | +22.78% | 0.00% |
LOGI | -0.07% | $11.51B | -9.19% | 1.76% |
NOVA | -0.10% | $429.84M | -67.33% | 0.00% |
GWW | 0.10% | $57.08B | +45.28% | 0.68% |
T | -0.11% | $163.09B | +40.40% | 4.87% |
CB | -0.11% | $114.43B | +26.00% | 1.24% |
CINF | -0.13% | $23.54B | +48.25% | 2.10% |
NWL | 0.13% | $3.67B | +20.00% | 3.04% |
BHVN | 0.14% | $4.67B | +56.79% | 0.00% |
QNTM | 0.15% | $9.19M | -94.36% | 0.00% |
RTO | 0.16% | $13.07B | -10.21% | 2.25% |
LMT | -0.17% | $126.40B | +18.99% | 2.36% |
AU | 0.18% | $10.58B | +41.93% | 0.90% |
HIG | -0.18% | $33.87B | +51.09% | 1.60% |
EDSA | -0.20% | $7.11M | -21.79% | 0.00% |
BALY | 0.20% | $726.31M | +54.50% | 0.00% |
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
APPS | 32.60% | $125.51M | -75.85% | 0.00% |
ZYME | 31.39% | $1.03B | +79.68% | 0.00% |
ATXS | 30.30% | $550.23M | +114.29% | 0.00% |
CRBU | 28.23% | $180.20M | -62.45% | 0.00% |
SUNS | 27.82% | $105.89M | +35.31% | 1.37% |
GPMT | 27.64% | $173.85M | -33.97% | 13.01% |
TBI | 26.82% | $199.52M | -50.80% | 0.00% |
BIGC | 26.49% | $473.42M | -31.75% | 0.00% |
SRI | 26.39% | $166.13M | -63.46% | 0.00% |
MRSN | 26.38% | $274.24M | +40.51% | 0.00% |
PRAA | 26.36% | $880.00M | +25.68% | 0.00% |
FWRD | 26.31% | $998.06M | -46.90% | 0.69% |
TXG | 26.27% | $1.64B | -68.30% | 0.00% |
GXO | 26.01% | $7.02B | +3.60% | 0.00% |
KALU | 25.93% | $1.29B | +34.50% | 3.84% |
OEC | 25.76% | $1.04B | -23.14% | 0.46% |
CENX | 25.76% | $2.13B | +184.86% | 0.00% |
ARRY | 25.00% | $926.85M | -60.03% | 0.00% |
TFII | 24.75% | $12.09B | +24.27% | 1.12% |
KALV | 24.60% | $440.88M | +17.08% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ALC | -20.14% | $42.14B | +18.10% | 0.31% |
OHI | -14.65% | $10.84B | +26.02% | 6.71% |
ACGL | -14.55% | $36.00B | +16.84% | 0.00% |
LNG | -14.08% | $49.37B | +24.99% | 0.82% |
VRSK | -12.65% | $39.77B | +17.45% | 0.53% |
VOD | -11.16% | $23.21B | -4.39% | 10.89% |
CNK | -10.93% | $4.09B | +138.59% | 0.00% |
PGR | -10.13% | $149.10B | +57.29% | 0.45% |
BPT | -9.96% | $24.61M | -66.18% | 0.00% |
ORLY | -9.94% | $69.31B | +22.06% | 0.00% |
FATBB | -9.91% | $81.94M | -12.91% | 11.69% |
RYAN | -9.85% | $8.81B | +55.63% | 0.62% |
GAN | -9.76% | $83.39M | +21.19% | 0.00% |
VIRT | -9.55% | $3.17B | +110.38% | 2.60% |
CTRE | -9.45% | $5.82B | +36.14% | 3.72% |
GRFS | -9.31% | $2.18B | -11.41% | 0.00% |
TW | -9.29% | $28.66B | +42.39% | 0.29% |
ONON | -9.13% | $17.09B | +91.60% | 0.00% |
FENG | -9.12% | $13.37M | +96.77% | 0.00% |
MSDL | -8.81% | $1.83B | +0.66% | 7.26% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPA | 34.56% | $273.87M | 0% |
IWC | 32.02% | $933.99M | 0.6% |
ARKG | 31.72% | $1.13B | 0.75% |
IWM | 30.81% | $75.73B | 0.19% |
IWO | 30.57% | $12.56B | 0.24% |
VTWO | 30.55% | $12.38B | 0.1% |
PSC | 29.86% | $702.17M | 0.38% |
EFAA | 29.82% | $117.38M | 0% |
GSSC | 29.74% | $529.86M | 0.2% |
XPH | 29.54% | $157.87M | 0.35% |
SLYG | 29.49% | $3.69B | 0.15% |
GRPM | 29.39% | $582.50M | 0.35% |
IJT | 29.38% | $6.64B | 0.18% |
IWN | 29.28% | $13.17B | 0.24% |
ISCG | 28.87% | $640.00M | 0.06% |
SPSM | 28.77% | $12.72B | 0.03% |
FYX | 28.61% | $959.00M | 0.6% |
DFAT | 28.55% | $11.16B | 0.28% |
VIOO | 28.52% | $3.12B | 0.1% |
PRFZ | 28.46% | $2.65B | 0.39% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -29.37% | $388.04M | 1.43% |
TAIL | -15.58% | $67.98M | 0.59% |
BSCO | -14.57% | $2.35B | 0.1% |
MUST | -12.31% | $410.00M | 0.23% |
VIXY | -11.79% | $195.31M | 0.85% |
JPST | -10.74% | $28.43B | 0.18% |
SCHO | -10.44% | $11.10B | 0.03% |
MUNI | -10.19% | $1.73B | 0.35% |
VGSH | -10.14% | $19.14B | 0.04% |
SPTI | -10.13% | $6.70B | 0.03% |
UCON | -10.10% | $3.19B | 0.85% |
FIXD | -9.97% | $5.51B | 0.65% |
SCHR | -9.89% | $9.97B | 0.03% |
IBDR | -9.61% | $2.93B | 0.1% |
FLGV | -9.50% | $850.15M | 0.09% |
UTEN | -9.47% | $149.75M | 0.15% |
IBTG | -9.34% | $1.48B | 0.07% |
BSV | -9.33% | $33.43B | 0.04% |
IBTL | -9.17% | $239.96M | 0.07% |
GOVI | -9.05% | $1.06B | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
YEAR | <0.01% | $1.13B | 0.25% |
IBTE | 0.01% | $1.70B | 0.07% |
BYLD | 0.02% | $232.64M | 0.15% |
PFFV | 0.04% | $257.84M | 0.25% |
DIAL | -0.05% | $368.52M | 0.28% |
CLOI | 0.09% | $715.40M | 0.4% |
IAK | -0.12% | $760.79M | 0.39% |
DFNM | -0.18% | $1.40B | 0.17% |
SHYD | 0.22% | $311.50M | 0.35% |
IGBH | -0.26% | $93.85M | 0.14% |
HIGH | 0.31% | $302.78M | 0.51% |
IBMM | 0.33% | $391.28M | 0.18% |
PHDG | -0.38% | $113.97M | 0.39% |
CTA | 0.54% | $350.27M | 0.78% |
PFLD | -0.55% | $457.09M | 0.46% |
TPMN | -0.56% | $40.60M | 0.65% |
HYD | 0.72% | $3.18B | 0.32% |
BSJQ | -0.86% | $773.39M | 0.42% |
FLMI | 0.99% | $356.19M | 0.3% |
EQLS | -1.01% | $76.08M | 1% |